Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.
01513.HK stock price ended at $29.96 on 木曜日, after rising 0.40%
On the latest trading day Feb 12, 2026, the stock price of 01513.HK rose by 0.40%, climbing from $30.06 to $29.96. Throughout the session, the stock experienced a volatility of 1.90%, with prices fluctuating between a daily low of $29.52 and a high of $30.08. Alongside this price increase, trading volume also rose by 348.9K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 719.4K shares were traded, amounting to a market value of approximately $8.9B.